Study Description

Lung cancers harboring activating EGFR mutants show dramatic responses to EGFR TKIs, such as Tarceva. However, nearly all patients show relapse... Show More

Study Accession Alternative Stable ID type
EGAS00001000793 Other

Publications

Data provider(s)

Who archives the data?

European Genome-phenome Archive